» Articles » PMID: 25187498

Drug Metabolism for the Paediatrician

Overview
Journal Arch Dis Child
Specialty Pediatrics
Date 2014 Sep 5
PMID 25187498
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Drug metabolism importantly determines drug concentrations. The efficacy and safety of many drugs prescribed for children are, therefore, dependent on intraindividual and interindividual variation in drug-metabolising enzyme activity. During growth and development, changes in drug-metabolising enzyme activity result in age-related differences in drug disposition, most pronounced in preterm infants and young infants. The shape of the developmental trajectory is unique to the drug-metabolising enzyme involved in the metabolism of individual drugs. Other factors impacting drug metabolism are underlying disease, drug-drug interactions and genetic variation. The interplay of age with these other factors may result in unexpected variation in drug metabolism in children of different ages. Extrapolation of adult data to guide drug dosing in children should be done with caution. The younger the child, the less reliable is the extrapolation. This review aims to identify the primary sources of variability of drug metabolism in children, the knowledge of which can ultimately guide the practitioner towards effective and safe drug therapy.

Citing Articles

Development and validation of individualized tacrolimus dosing software for Chinese pediatric liver transplantation patients: a population pharmacokinetic approach.

Yang S, Wei J, Pan X, Li Z, Zhang X, Li Z Eur J Clin Pharmacol. 2024; 80(9):1409-1420.

PMID: 38904798 DOI: 10.1007/s00228-024-03717-2.


The Capacity of Drug-Metabolising Enzymes in Modulating the Therapeutic Efficacy of Drugs to Treat Rhabdomyosarcoma.

Picher E, Wahajuddin M, Barth S, Chisholm J, Shipley J, Pors K Cancers (Basel). 2024; 16(5).

PMID: 38473371 PMC: 10930814. DOI: 10.3390/cancers16051012.


Population Pharmacokinetics and Pharmacogenetics Analyses of Dasatinib in Chinese Patients with Chronic Myeloid Leukemia.

He S, Zhao J, Bian J, Zhao Y, Li Y, Guo N Pharm Res. 2023; 40(10):2413-2422.

PMID: 37726405 DOI: 10.1007/s11095-023-03603-z.


Epigenetic Mechanisms Contribute to Intraindividual Variations of Drug Metabolism Mediated by Cytochrome P450 Enzymes.

Jin J, Zhong X Drug Metab Dispos. 2023; 51(6):672-684.

PMID: 36973001 PMC: 10197210. DOI: 10.1124/dmd.122.001007.


Practice of CYP450 genotyping and phenotyping in children in a real-life setting.

Rodieux F, Daali Y, Rollason V, Samer C, Ing Lorenzini K Front Pharmacol. 2023; 14:1130100.

PMID: 36937881 PMC: 10022732. DOI: 10.3389/fphar.2023.1130100.